Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score

NCT03336463 is registered in ClinicalTrials.gov with Ferrer inCode, S.L. as lead sponsor.

NCT NCT03336463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score
Lead sponsor
Ferrer inCode, S.L.
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
January 31, 2017
Enrollment
364 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

miscarriage, recurrent